Thursday, 19 September 2019, 09:30 - 11:00, Hall 4.2
Chair: Solomon Tesfaye, UK / Peter Kempler, HU
Peter Kempler, HU: Welcome and introduction: Should diabetic neuropathy be considered as an early and severe complication?
Nikolaos Papanas, GR: Praediabetic neuropathy
Dinesh Selvarajah, UK: Seeing what they are feeling: central mechanisms determining clinical phenotype and treatment response in diabetic neuropathy
Viktor Horváth, HU: The effect of autonomic and sensory neuropathy on all-cause mortality - a 20 year long retrospective cohort study
Dan Ziegler, DE: "This house believes that diabetic neuropathy is reversible" Summary on pathogenetic oriented disease-modifying therapy in diabetic neuropathy
Solomon Tesfaye, UK: Update on symptomatic treatment of diabetic neuropathy